Literature DB >> 19838081

Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma.

Hirotake Takai1, Motohki Ashihara, Takahiro Ishiguro, Hiromichi Terashima, Takeshi Watanabe, Atsuhiko Kato, Masami Suzuki.   

Abstract

Previously, we demonstrated that membrane expression of glypican-3 (GPC3) stimulates the recruitment of macrophages into human hepatocellular carcinoma (HCC) tissues. However, functional polarization of the macrophages and the chemoattractant factors related to the recruitment has yet to be determined. In this study, to clarify the polarization (M1 or M2) of the macrophages and provide a clue as to the factors involved in the recruitment, we used xenograft models of SK-HEP-1 and SK03 cell lines with undetectable and high-level membrane expression of GPC3, respectively and analyzed the expression profiles of the relevant genes in both xenografts mainly using microarray techniques. Clustering analyses with mouse genome arrays revealed that the SK-HEP-1 and SK03 xenografts showed different expression profiles for M2 macrophage-related genes but not for M1 macrophage-related genes. Many of the M2 macrophage-related genes were upregulated in the SK03 xenografts compared to the SK-HEP-1 xenografts. Additionally, most of the macrophages infiltrating into the SK03 xenografts were positive for M2 macrophage-specific markers. Regarding the chemoattractant factors, the microarray and quantitative real-time PCR analyses revealed that, of the genes reportedly related to macrophage recruitment, CCL5, CCL3 and CSF1 were significantly upregulated in the SK03 xenograft. These findings suggest that the macrophages recruited into GPC3-overexpressing (with membrane expression) HCC are M2-polarized ones and, more specifically, M2 tumor-associated macrophages which are known to promote tumor progression and metastasis, and CCL5, CCL3 and CSF1 are possible candidate genes for the recruitment of macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19838081     DOI: 10.4161/cbt.8.24.9985

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  29 in total

Review 1.  Targeting the tumor stroma in hepatocellular carcinoma.

Authors:  Femke Heindryckx; Pär Gerwins
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Role of tumor-associated macrophages in the progression of hepatocellular carcinoma.

Authors:  Ken Shirabe; Yohei Mano; Jun Muto; Rumi Matono; Takashi Motomura; Takeo Toshima; Kazuki Takeishi; Hidekaki Uchiyama; Tomoharu Yoshizumi; Akinobu Taketomi; Masaru Morita; Shunichi Tsujitani; Yoshihisa Sakaguchi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-11-25       Impact factor: 2.549

3.  SALL4-mediated upregulation of exosomal miR-146a-5p drives T-cell exhaustion by M2 tumor-associated macrophages in HCC.

Authors:  Chunlai Yin; Qiuju Han; Dongqing Xu; Bingqing Zheng; Xuemei Zhao; Jian Zhang
Journal:  Oncoimmunology       Date:  2019-04-17       Impact factor: 8.110

4.  Early transcriptional responses of HepG2-A16 liver cells to infection by Plasmodium falciparum sporozoites.

Authors:  Rana Chattopadhyay; Patricia de la Vega; Sun H Paik; Yoko Murata; Earl W Ferguson; Thomas L Richie; Guck T Ooi
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

5.  Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients.

Authors:  Yanhui Xu; Hong Li; Rui Lin Gao; Oluwasayo Adeyemo; Maxim Itkin; David E Kaplan
Journal:  Clin Immunol       Date:  2011-02-26       Impact factor: 3.969

Review 6.  Glypican-3: a new target for cancer immunotherapy.

Authors:  Mitchell Ho; Heungnam Kim
Journal:  Eur J Cancer       Date:  2010-11-26       Impact factor: 9.162

7.  Generation of functional CD8+ T cells by human dendritic cells expressing glypican-3 epitopes.

Authors:  James O'Beirne; Farzin Farzaneh; Phillip M Harrison
Journal:  J Exp Clin Cancer Res       Date:  2010-05-13

8.  Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.

Authors:  Mikiko Nakamura; Chao Xu; Cheikh Diack; Norihisa Ohishi; Ruey-Min Lee; Satofumi Iida; Takehiko Kawanishi; Toshihiko Ohtomo; Ghassan K Abou-Alfa; Ya-Chi Chen
Journal:  Br J Clin Pharmacol       Date:  2018-03-09       Impact factor: 4.335

9.  The role of glypican-3 in regulating Wnt in hepatocellular carcinomas.

Authors:  Wei Gao; Mitchell Ho
Journal:  Cancer Rep       Date:  2011

10.  SJSZ glycoprotein (38 kDa) modulates macrophage type 1/2-related factors at hepatocarcinogenic stage in N-nitrosodiethylamine-treated Balb/c.

Authors:  Jin Lee; Kye-Taek Lim
Journal:  Mol Cell Biochem       Date:  2012-09-07       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.